CARTEXAN

This brand name is authorized in Austria, Finland, Poland

Active ingredients

The drug CARTEXAN contains one active pharmaceutical ingredient (API):

1 Chondroitin sulfate
UNII 6IC1M3OG5Z - CHONDROITIN SULFATE (BOVINE)

Chondroitin sulfate belongs to the polysaccharide subgroup of glycosaminoglycans. Chondroitin sulfate is one of the main elements of the cartilage, which joins a central protein, forming what we know as proteoglycan, which is what gives the cartilage its mechanical and elastic properties.

Read about Chondroitin sulfate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
M01AX25 Chondroitin sulfate M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AX Other antiinflammatory and antirheumatic agents, non-steroids
Discover more medicines within M01AX25

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 050463, 533824
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100328720

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.